Marque Millennium Capital Management’s Celgene Corp CELG Stock Holding History

Marque Millennium Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-17,500	Closed	-$2.02M	–	81
2015 Q1	$2.02M	Hold	17,500	–	–	0.79%	55
2014 Q4	$1.96M	Hold	17,500	–	–	0.77%	53
2014 Q3	$1.66M	Hold	17,500	–	–	0.67%	57
2014 Q2	$1.5M	Hold	17,500	–	–	0.6%	62
2014 Q1	$1.22M	Hold	17,500	–	–	0.51%	65
2013 Q4	$1.48M	Hold	17,500	–	–	0.65%	61
2013 Q3	$1.35M	Hold	17,500	–	–	0.66%	59
2013 Q2	$1.02M	Buy	+17,500	New	+$1.05M	0.54%	65

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marque Millennium Capital Management's CELG Position: Q2 2015 in Review

Marque Millennium Capital Management sold out of Celgene Corp (CELG) in Q2 2015, closing a stake of 17,500 shares — an estimated $2.02M sold.

Marque Millennium Capital Management first reported a position in CELG in Q2 2013 and held it in 8 quarters. The position peaked at $2.02M in Q1 2015. 1,201 funds tracked by Wall St. Rank hold CELG as of Q2 2015.

Marque Millennium Capital Management reported no remaining Celgene Corp position as of Q2 2015 after selling out during the quarter.
Marque Millennium Capital Management sold 17,500 Celgene Corp shares in Q2 2015, an estimated $2.02M.
Marque Millennium Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 8 quarters.
Marque Millennium Capital Management's Celgene Corp position peaked at $2.02M in Q1 2015.
1,201 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2015.

Based on Marque Millennium Capital Management's 13F filing for Q2 2015, filed 21 Jul 2015.